Three dimensional ultrasound and prostate cancer. by Mehta, S, Azzouzi, A, Hamdy, F

The use of proteomics in urological research by Rehman, I, Azzouzi, A, Catto, J, Hamdy, F

Gli1 appears to be constitutively expressed in the lumenal epithelial cells of the prostate but not in the basal cell layer or the mesenchyme by Spencer, A, Bury, J, Feeley, K, Azzouzi, A, Hamdy, F, Cross, S

Loss of intercellular expression of beta-dystroglycan is a common event in prostate cancer and is significantly associated with loss of differentiation by Cross, S, Hollingbury, F, Lippitt, J, Feeley, K, Azzouzi, A, Winder, S, Hamdy, F

DNA promoter methylation in urothelial cancer: a feature of the invasive phenotype and a novel therapeutic target by Catto, J, Dhawan, D, Meuth, M, Cussenot, O, Azzouzi, A, Hamdy, F

Tissue microarray immunohistochemistry and cluster analysis confirms the validity of candidate proteins in prostate cancer identified by proteomic analysis of urine by Rehman, I, Harrison, R, Leiblich, A, Catto, J, Azzouzi, A, Cross, S, Hamdy, F

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma. by Rouprêt, M, Fromont, G, Azzouzi, A, Catto, J, Vallancien, G, Hamdy, F, Cussenot, O

Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study. by Rehman, I, Azzouzi, A, Catto, J, Allen, S, Cross, S, Feeley, K, Meuth, M, Hamdy, F

Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer. by Rehman, I, Cross, S, Catto, J, Leiblich, A, Mukherjee, A, Azzouzi, A, Leung, H, Hamdy, F

Les entérobactéries sécrétrices de béta-Lactamases à spectre étendu en urologie à l’Hôpital Ibn Sina de Rabat by Kone J, Bellahcen B, Awab A, El Moussaoui R, Alilou M, El Hijri A, Azzouzi A

Get full text

Proteomic analysis of voided urine following prostatic massage reveals tumour specific alterations by Rehman, I, Azzouzi, A, Catto, J, Allen, S, Cross, S, Feeley, K, Eaton, C, Meuth, M, Hamdy, F

Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions. by Rehman, I, Azzouzi, A, Cross, S, Deloulme, J, Catto, J, Wylde, N, Larre, S, Champigneuille, J, Hamdy, F

Behavior of urothelial carcinoma with respect to anatomical location. by Catto, J, Yates, DR, Rehman, I, Azzouzi, A, Patterson, J, Sibony, M, Cussenot, O, Hamdy, F

Proteomics and immunohistochemistry identify loss of nucleophosmin (B23) expression in bladder transitional cell carcinomas by Ahmad, M, Catto, J, Azzouzi, A, Cross, S, Feeley, K, Eaton, C, Meuth, M, Hamdy, F, Rehman, I

FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours. by van Oers, J, Zwarthoff, E, Rehman, I, Azzouzi, A, Cussenot, O, Meuth, M, Hamdy, F, Catto, J

Clinically localised prostate cancer is microsatellite stable. by Azzouzi, A, Catto, J, Rehman, I, Larre, S, Roupret, M, Feeley, K, Cussenot, O, Meuth, M, Hamdy, F

S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors. by Rehman, I, Cross, S, Azzouzi, A, Catto, J, Deloulme, J, Larre, S, Champigneuille, J, Fromont, G, Cussenot, O, Hamdy, F

Calgizzarin (S100A11) immunostaining pattern is altered in prostate cancer suggesting a role in tumourigenesis by Rehman, I, Azzouzi, A, Catto, J, Ahmad, M, Deloulme, U, Cross, S, Feeley, K, Eaton, C, Meuth, M, Hamdy, F

Distinct patterns of microsatellite instability are seen in tumours of the urinary tract. by Catto, J, Azzouzi, A, Amira, N, Rehman, I, Feeley, K, Cross, S, Fromont, G, Sibony, M, Hamdy, F, Cussenot, O, Meuth, M

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. by Catto, J, Azzouzi, A, Rehman, I, Feeley, K, Cross, S, Amira, N, Fromont, G, Sibony, M, Cussenot, O, Meuth, M, Hamdy, F